Circulating tumor cells: evolving evidence and future challenges.
暂无分享,去创建一个
Neal J Meropol | K. Alpaugh | N. Meropol | Steven J Cohen | Efrat Dotan | E. Dotan | Katherine R Alpaugh | S. Cohen
[1] P. Steeg. Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.
[2] U. Metzger,et al. Disseminated Single Tumor Cells as Detected by Real-Time Quantitative Polymerase Chain Reaction Represent a Prognostic Factor in Patients Undergoing Surgery for Colorectal Cancer , 2002, Annals of surgery.
[3] Robert Rosenberg,et al. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[4] Mehmet Toner,et al. The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients. , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[5] T. Aoki,et al. Detection and evaluation of epithelial cells in the blood of colon cancer patients using RT-PCR , 2006, International Journal of Clinical Oncology.
[6] M. Noble,et al. Cancer stem cells. , 2006, The New England journal of medicine.
[7] S Miltenyi,et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. , 1998, Experimental hematology.
[8] H. Scher,et al. Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer , 2007, Clinical Cancer Research.
[9] G. T. Budd,et al. Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival , 2006, Clinical Cancer Research.
[10] M. Dowsett,et al. Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques , 2005, British Journal of Cancer.
[11] Jonathan W. Uhr,et al. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.
[12] R. Butler,et al. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. , 1993, Cancer research.
[13] J. Clements,et al. Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression , 2007, Journal of cellular physiology.
[14] S. Digumarthy,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.
[15] A. Adjei,et al. Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor , 2007, Clinical Cancer Research.
[16] Brigitte Rack,et al. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.
[17] D. Mavroudis,et al. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] J. Uhr,et al. Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. , 2002, International journal of oncology.
[19] L. Weiner,et al. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. , 2006, Clinical colorectal cancer.
[20] W. J. Allard,et al. Circulating tumor cells predict survival in patients with metastatic prostate cancer. , 2005, Urology.
[21] L. Fink,et al. Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors , 2009, Cancer Epidemiology Biomarkers & Prevention.
[22] G. Kallergi,et al. Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer , 2008, Clinical Cancer Research.
[23] K. Schütze,et al. Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.
[24] Leon W.M.M. Terstappen,et al. Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer , 2006, Clinical Cancer Research.
[25] Li Zhang,et al. Preliminary Investigation of the Clinical Significance of Detecting Circulating Tumor Cells Enriched from Lung Cancer Patients , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[26] Stefan Sleijfer,et al. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. , 2009, Cancer treatment reviews.
[27] D. Dearnaley,et al. Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[28] U. Metzger,et al. Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer , 2003, The British journal of surgery.
[29] T. Fehm,et al. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status , 2007, Breast Cancer Research.
[30] Annibale Biggeri,et al. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients , 2009, Breast Cancer Research and Treatment.
[31] Y. Takagi,et al. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. , 2000, Annals of surgery.
[32] C. Sotiriou,et al. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] W. Grody,et al. The Clinical Significance of Circulating Tumor Cells in the Peripheral Blood , 2006, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[34] K. Pienta,et al. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.
[35] P. Paterlini-Bréchot,et al. Circulating tumor cells (CTC) detection: clinical impact and future directions. , 2007, Cancer letters.
[36] D. Hayes,et al. The measurement and therapeutic implications of circulating tumour cells in breast cancer , 2005, British Journal of Cancer.
[37] A. Lacy,et al. Prognostic Value of Postoperative Detection of Blood Circulating Tumor Cells in Patients With Colorectal Cancer Operated on For Cure , 2003, Annals of surgery.
[38] Glenn Heller,et al. Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer , 2007, Clinical Cancer Research.
[39] E. Slodkowska,et al. Circulating and disseminated tumor cells in the management of breast cancer. , 2009, American journal of clinical pathology.
[40] S. Rodenhuis,et al. Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence–based amplification for the detection of circulating breast cancer cells , 1999, Breast Cancer Research and Treatment.
[41] Alessandro Ambrosi,et al. The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis , 2006, Clinical Cancer Research.
[42] S. Yasuda,et al. Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase‐polymerase chain reaction , 2001, Cancer.
[43] Michael L Pearl,et al. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. , 2009, Gynecologic oncology.
[44] Peter Kuhn,et al. High speed detection of circulating tumor cells. , 2006, Biosensors & bioelectronics.
[45] Tanja Fehm,et al. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients , 2009, Breast Cancer Research.
[46] Xiaoyu Jia,et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. , 2009, The Lancet. Oncology.
[47] R. Coombes,et al. Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] J. Nesland,et al. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method. , 2004, Cytotherapy.
[49] R. Babaian,et al. Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer. , 2008, The Journal of urology.
[50] R. Bast,et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[52] F. Orr,et al. Cancer cell interactions with injured or activated endothelium , 1992, Cancer and Metastasis Reviews.
[53] F. Itokawa,et al. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. , 2008, Journal of hepato-biliary-pancreatic surgery.
[54] M. Naoe,et al. Detection of circulating urothelial cancer cells in the blood using the CellSearch System , 2007, Cancer.
[55] J. Goeminne,et al. Pitfalls in the detection of disseminated non-hematological tumor cells. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[56] Kristine Broglio,et al. Circulating tumor cells in metastatic breast cancer , 2008, Cancer.
[57] C. Glover,et al. Clearance of Circulating Tumor Cells After Excision of Primary Colorectal Cancer , 2002, Annals of surgery.
[58] C. Punt,et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[59] M. Rubin,et al. Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase‐polymerase chain reaction assay in patients with early stage prostate carcinoma , 1997, Cancer.
[60] Alison Stopeck,et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.
[61] K. Pienta,et al. Global gene expression profiling of circulating tumor cells. , 2005, Cancer research.
[62] U. Demel,et al. Detection of tumour cells in the peripheral blood of patients with breast cancer. Development of a new sensitive and specific immunomolecular assay. , 2004, Journal of experimental & clinical cancer research : CR.
[63] L. Tanoue,et al. Detection of Mutations in EGFR in Circulating Lung-Cancer Cells , 2010 .
[64] O. Böcher,et al. The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients. , 2007, Anticancer research.
[65] Dieter Lutz,et al. Tumor cell detection in peripheral blood and bone marrow , 2006, Current opinion in oncology.
[66] Hellmut Samonigg,et al. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients , 2005, Cytometry. Part B, Clinical cytometry.
[67] C. Glover,et al. Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma , 2007, The British journal of surgery.
[68] A. Weiss,et al. Detection and characterization of carcinoma cells in the blood. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[69] Oscar Lin,et al. Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer , 2009, Clinical Cancer Research.
[70] Alison Stopeck,et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] Tanja Fehm,et al. HER-2 gene amplification can be acquired as breast cancer progresses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[72] Evan T Keller,et al. Detection and isolation of circulating tumor cells in urologic cancers: a review. , 2004, Neoplasia.
[73] A. Choy,et al. Detection and enumeration of circulating tumour cells in colorectal cancer , 1993, The British journal of surgery.
[74] N. Kaibara,et al. Prognostic significance of reverse transcriptase‐polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma , 2000, Cancer.
[75] W. Gerald,et al. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] Michael Morse,et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.